Genetic Testing for All Breast Cancer Patients (GET FACTS)

Completed · Not applicable

Conditions studied: Breast Cancer, Invasive Breast Cancer, in Situ Breast Cancer, Genetic Testing

In brief

This study is designed to determine the impact of a novel genetic counseling method on surgical decisions in individuals with newly diagnosed breast cancer This research study involves an expedited and surgery-specific form of genetic counseling. The names of the study methods involved in this trial are/is: * Quantitative genetic counseling (discussion is guided by tables and graphs) * Standard genetic counseling

Key facts

Study ID

NCT04245176

Run by

Brigham and Women's Hospital

People needed

400

Starts

2020-01-31

Expected to finish

2026-01-01

Last updated by the study team

2026-05-04

Who can join

Age: 18 and older, up to 79. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients with a new breast cancer diagnosis (invasive or in-situ) considering genetic testing
• Patients with good understanding of written and spoken English
• Patients with apparent cognitive capacity to make surgical decisions for themselves
• Patients who are medically cleared for surgery
• Patients must be at least age 18 but under 79

You may not qualify if…

• Previous breast cancer diagnosis (invasive or DCIS)
• Metastatic breast cancer
• Patients who have received prior broad-based panel testing (prior BRCA1/2 testing with negative results allowed)
• Bilateral breast cancer
• Known medical or surgical contraindication to contralateral mastectomy
• Hematologic malignancy necessitating skin biopsy/fibroblast culture for germline genetic testing malignancy other than cervical cis or basal or squamous cell skin cancers.

Where it is running

• Dana Farber Cancer Institute — Boston, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.